Paliperidone for Schizophrenia – Bangladesh Safety Study
Part of Mental health clinical trials.
This trial tests a medication called paliperidone for adults with schizophrenia. If you have been diagnosed for at least 3 months and haven't had success with one antipsychotic or haven't taken any yet, this study might help find a treatment that works better for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have been diagnosed with schizophrenia (by a doctor) for at least 3 months.
- You either have never taken antipsychotic medication OR you have tried only one antipsychotic and it didn't work well or caused bad side effects (and you can stop it for 7 days before starting the study drug).
- You are not pregnant or breastfeeding.
- You do not have a serious medical condition (like severe heart, kidney, or liver disease) and have not had a substance abuse problem in the past month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a new version of an extended-release injection is as effective as the original in people with schizophrenia. The study helps ensure patients have access to a reliable treatment option.
This study tests switching from a long-acting injectable antipsychotic (paliperidone palmitate) to daily oral antipsychotics in people with schizophrenia who are currently stable. The goal is to see if the switch helps maintain symptom control and improve daily functioning.
This trial tests a new medication called LB-102 for people with acute (sudden worsening of) schizophrenia. It aims to see if the drug helps reduce symptoms like hallucinations or disorganized thinking.
This study looks at long-acting (extended-release) antipsychotic medicine options in people with schizophrenia, compared with regular tablets. You may be able to join if you were already part of a related earlier study or its real-world follow-up.
This study tests the long-term safety of an investigational medication for schizophrenia over one year. It may be an option if you are currently stable on your antipsychotic medication.
This trial tests an investigational drug called brenipatide for people with schizophrenia who are already on a stable medication regimen. The goal is to see if adding this drug helps reduce relapses.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.